MBD2 and amyotrophic lateral sclerosis: This trend was sustained at day 7 with a concomitant decrease in METTL3/14 expression, together with significantly increased expression of the demethylases FTO and ALKBH5 in most of the ALS iPSC~MNs (Supplementary Fig. 1e).